[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Guangdong Jiaying Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Guangdong Jiaying Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Guangdong Kangmei Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Guangdong Kangmei Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Guangxi Wuzhou Zhongheng Group Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Guangxi Wuzhou Zhongheng Group Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Guangzhou Improve Medical Instruments Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Guangzhou Improve Medical Instruments Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Guangzhou Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Guangzhou Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Guangzhou Xiangxue Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Guangzhou Xiangxue Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Gufic Biosciences Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Gufic Biosciences Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Guilin Sanjin Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Guilin Sanjin Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Guizhou Bailing Group Pharmaceutical Co.,Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Guizhou Bailing Group Pharmaceutical Co.,Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Guizhou Xinbang Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Guizhou Xinbang Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Guizhou Yibai Pharmaceutical Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Guizhou Yibai Pharmaceutical Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Gujarat Terce Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Gujarat Terce Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Gujarat Themis Biosyn Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Gujarat Themis Biosyn Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Gulf Pharmaceutical Industries Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Gulf Pharmaceutical Industries Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

GW Pharmaceuticals plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

GW Pharmaceuticals plc Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

H. Lundbeck A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

H. Lundbeck A/S Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hainan Haiyao Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hainan Haiyao Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hainan Honz Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hainan Honz Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Halozyme Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Halozyme Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hamilton Thorne Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hamilton Thorne Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

HanAll Biopharma Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

HanAll Biopharma Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Handok Pharmaceuticals Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Handok Pharmaceuticals Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hangzhou Tian-Mu-shan Pharmaceutical Enterprise Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hangzhou Tian-Mu-shan Pharmaceutical Enterprise Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hanmi Science Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hanmi Science Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hanmi Pharm. Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hanmi Pharm. Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hans Biomed Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hans Biomed Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hansa Medical AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hansa Medical AB Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hao Wen Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hao Wen Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Harbin Gloria Pharmaceuticals Co., Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Harbin Gloria Pharmaceuticals Co., Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 86 pages

Harbin Pharm Group Sanjing Pharmaceutical Shareholding Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Harbin Pharm Group Sanjing Pharmaceutical Shareholding Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Harbin Pharmaceutical Group Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Harbin Pharmaceutical Group Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Harbor BioSciences, Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Harbor BioSciences, Inc Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Harleystreet Pharmaceuticals Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Harleystreet Pharmaceuticals Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Harvard Bioscience Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Harvard Bioscience Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

HBL Hadasit Bio Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

HBL Hadasit Bio Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

HC Berlin Pharma AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

HC Berlin Pharma AG Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

HealthLinx Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

HealthLinx Limited Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

HealthRenu Medical Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

HealthRenu Medical Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Helicon Group Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Helicon Group Limited Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Helicos BioSciences Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Helicos BioSciences Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Helix Biomedix Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Helix Biomedix Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Helix Biopharma Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Helix Biopharma Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hemispherx Biopharma, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hemispherx Biopharma, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hemobiotech Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hemobiotech Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Henan Lingrui Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Henan Lingrui Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Henan Taloph Pharmaceutical Stock Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Henan Taloph Pharmaceutical Stock Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Henan Topfond Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Henan Topfond Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hepahope Korea Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hepahope Korea Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Hero International USA Holding Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Hero International USA Holding Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

May 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers